The initial reports of mifepristone, an antiprogestogen, therapy for unresectable meningiomas showed opposite effects in the small number of patients treated40, and some patients who received therapy with the selective estrogen receptor modulator tamoxifen for breast-cancer appear to have been protected from meningiomas41,42. This evidence concerns the gene ESR1 and breast cancer.